You are here
Angiochem dans l’actualité
Angiochem est régulièrement sous les feux de l’actualité depuis sa création en 2003. Cette page présente les derniers récits sur Angiochem et la technologie EPiC.
Prof Tang speaks with ecancertv at ESMO 2016 about successes with ANG1005, a conjugate of paclitaxel with a peptide which can cross the blood brain barrier.
Watch the video.
Angiochem was named by Fierce Biotech one of the “Fierce 15” biotech companies of 2012 for its innovation in biotechnology.
Read the article
Angiochem was presented with the Innovation Recognition Award from the National Brain Tumor Society for its progress in developing novel treatments for brain tumors that are capable of crossing the blood-brain barrier.
Read the news release
The reputable Montreal daily newspaper showcases Angiochem’s work in developing treatments for brain cancer and brain-related diseases in its Innovation section.